Carel F W Peeters
Overview
Explore the profile of Carel F W Peeters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Del Campo M, Quesada C, Vermunt L, Peeters C, Hok-A-Hin Y, Trieu C, et al.
Mol Neurodegener
. 2024 Nov;
19(1):82.
PMID: 39523360
This preclinical AD CSF proteome study identified a panel of 12-CSF markers detecting amyloid positivity and clinical progression to AD with high accuracy; some of these CSF proteins related to...
2.
Hok-A-Hin Y, Vermunt L, Peeters C, van der Ende E, de Boer S, Meeter L, et al.
medRxiv
. 2024 Sep;
PMID: 39228745
Diagnosis of Frontotemporal dementia (FTD) and the specific underlying neuropathologies (frontotemporal lobar degeneration; FTLD- Tau and FTLD-TDP) is challenging, and thus fluid biomarkers are needed to improve diagnostic accuracy. We...
3.
Bartzis G, Peeters C, Ligterink W, van Eeuwijk F
BMC Bioinformatics
. 2024 May;
25(1):202.
PMID: 38816801
Intoduction: In systems biology, an organism is viewed as a system of interconnected molecular entities. To understand the functioning of organisms it is essential to integrate information about the variations...
4.
Reus L, Jansen I, Tijms B, Visser P, Tesi N, van der Lee S, et al.
Brain
. 2024 Mar;
147(10):3522-3533.
PMID: 38527854
Genome-wide association studies have successfully identified many genetic risk loci for dementia, but exact biological mechanisms through which genetic risk factors contribute to dementia remains unclear. Integrating CSF proteomic data...
5.
Del Campo M, Vermunt L, Peeters C, Sieben A, Hok-A-Hin Y, Lleo A, et al.
Nat Commun
. 2023 Sep;
14(1):5635.
PMID: 37704597
Diagnosis of dementia with Lewy bodies (DLB) is challenging and specific biofluid biomarkers are highly needed. We employed proximity extension-based assays to measure 665 proteins in the cerebrospinal fluid (CSF)...
6.
Del Campo M, Peeters C, Johnson E, Vermunt L, Hok-A-Hin Y, van Nee M, et al.
Nat Aging
. 2023 Apr;
2(11):1040-1053.
PMID: 37118088
Development of disease-modifying therapies against Alzheimer's disease (AD) requires biomarkers reflecting the diverse pathological pathways specific for AD. We measured 665 proteins in 797 cerebrospinal fluid (CSF) samples from patients...
7.
Santoso A, Jansen F, Peeters C, Baatenburg de Jong R, Brakenhoff R, Langendijk J, et al.
Curr Oncol
. 2022 Oct;
29(10):7109-7121.
PMID: 36290836
Psychoneurological symptoms are commonly reported by newly diagnosed head and neck cancer (HNC) patients, yet there is limited research on the associations of these symptoms with biomarkers of stress and...
8.
Munch M, van de Wiel M, van der Vaart A, Peeters C
Biom J
. 2022 Jun;
64(7):1289-1306.
PMID: 35730912
The features in a high-dimensional biomedical prediction problem are often well described by low-dimensional latent variables (or factors). We use this to include unlabeled features and additional information on the...
9.
Klarenberg H, Dekkers I, Peeters C, de Mutsert R, Jukema J, Rosendaal F, et al.
J Diabetes Complications
. 2022 May;
36(6):108202.
PMID: 35491309
Aims: To quantify metabolic impairment via a one-factor approach with confirmatory factor analysis (CFA) including MRI-derived visceral and subcutaneous adipose tissues and to associate it with diastolic dysfunction. Methods: In...
10.
van Balkom T, Berendse H, van der Werf Y, Twisk J, Peeters C, Hoogendoorn A, et al.
Parkinsonism Relat Disord
. 2022 Mar;
96:80-87.
PMID: 35248830
Introduction: Cognitive training (CT) has been proposed as a treatment option for cognitive impairment in Parkinson's disease (PD). We aimed to assess the efficacy of adaptive, computerized CT on cognitive...